Meropenem Kabi

Meropenem, the active ingredient in Meropenem Kabi, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired and ventilator‑associated pneumonia, as well as severe sepsis and septic shock.

GNH USA supplies Meropenem Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and other healthcare facilities worldwide.

Meropenem Kabi is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

Complicated intra‑abdominal infections: provides rapid bacterial eradication in patients with intra‑abdominal sepsis. Complicated urinary tract infections: clears resistant Gram‑negative pathogens in complicated UTIs. Hospital‑acquired pneumonia: treats multidrug‑resistant organisms causing nosocomial pneumonia. Ventilator‑associated pneumonia: effective against pathogens in ventilated patients. Severe sepsis and septic shock: used as empiric therapy for life‑threatening systemic infections.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruptions. - Infusion site reactions: pain, erythema, or phlebitis. - Elevated liver enzymes: transient increase in ALT/AST. - Increased serum creatinine: mild renal function changes.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with pre‑existing CNS disorders or high doses. - Clostridioides difficile infection: risk of severe colitis. - Severe neutropenia or thrombocytopenia: marked reduction in blood cell counts. - Acute renal failure: rapid decline in kidney function. - Hepatotoxicity: rare but significant liver injury.

Meropenem Kabi should be used with caution in specific clinical situations. - Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Pregnancy: prescribe only when the potential benefit justifies the potential risk to the fetus. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Superinfection: watch for secondary fungal or C. difficile infections. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem Kabi may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk. - Probenecid: may raise meropenem concentrations, heightening toxicity. - Aminoglycosides: combined use can amplify nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of meropenem. - Anticoagulants (e.g., warfarin): monitor INR for potential bleeding. - Oral contraceptives: possible reduction in contraceptive efficacy, advise additional protection.